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Combining a minimalist naproxen N-capped dehydrodipeptide hydrogelator block with a peptide bioepitope, 
illustrated in this work by the Npx-L-Ala-Z-∆Phe-G-R-G-D-G-OH construct, is an efficient approach to produce 
functional hydrogels.  
 
Peptide-based self-assembled hydrogels trigged remarkable research interest in recent years owing to 
biocompatibility and biomimetic properties and responsiveness, which warrant many technological and 
biomedical applications. Dehydrodipeptides N-capped with naproxen emerged from our research as 
effective hydrogelators endowed with resistance to proteolysis. Dehydrodipeptide-based 
hydrogels are promising nanocarriers for drug delivery applications. In this work we demonstrate 
that dehydrodipetide Npx-L-Ala-Z-ΔPhe-OH can be deployed as a minimalist hydrogelator module for 
synthesizing a gelating construct   Npx-L-Ala-Z-Phe-G-R-G-D-G-OH bearing a GRGDG adhesion 
motif. The self-assembly of the peptide construct and the drug delivery properties of the hydrogel were 
studied in this work. The peptide construct showed no toxicity towards a fibroblast cell line 
expressing the integrin. Docking studies suggest that the hydrogelator block does not 
interfere with the recognition of the RGD motif by the integrin receptor. The   Self-assembly 
seems to be directed by intermolecular naftalene - stacking interactions, with the peptide 
backbone assuming a random coil conformation both in solution and in gel phase.  TEM and 
STEM imaging revealed that the hydrogel is made of entangled bundles of long thin fibres (width 
circa 23 nm). The hydrogel exhibits viscoelastic properties, thermo-reversibility and recovery 
after mechanical fluidization. FRET studies showed that curcumin incorporated into the hydrogel 
interacts non-covalently with the hydrogel fibrils. Delivery of curcumin from the hydrogel into 
Nile-red loaded model membranes (SUVs) was demonstrated by FRET. 
Naproxen N-capped dehydrodipeptides are efficacious minimalist hydrogelator modules for 
obtaining hydrogels functionalized with peptide ligands for cell receptors. These hydrogels are 
potential nanocarriers for drug delivery. 
 
 
 
Introduction 
An increase of the span of human live to unprecedented levels it is to 
be expected during this century. This will certainly demand future 
developments in areas such as tissue engineering and regenerative 
medicine.  Unnatural scaffolds, structural and functional surrogates 
of the Extracellular Matrix (ECM), are essential to foster future 
developments on stem cell therapies, tissue engineering and 
regenerative medicine.1 Beyond its role as structural scaffold for cell 
growth, the ECM presents a variety of physical, chemical and 
biochemical cues to cells that direct adhesion, differentiation, 
proliferation and migration.2 Micro- nanostructured matrices that 
create a highly hydrated porous 3D environment are the most 
promising ECM surrogates. Synthetic and natural polymer-based 
hydrogels3 and self-assembled hydrogels4 are the most efficacious 
scaffolds for tissue engineering. In nature, complex functional  
biological structures are built by spontaneous hierarchical assembly, 
self-assembly,  of a limited number of simpler blocks driven by an 
array of cooperative non-covalent interactions: electrostatic, dipole-
dipole, van der Waals, π-π stacking and hydrogen bonding.5 Self-
assembly has become also  the privileged methodology for bottom-
up construction of complex nanostructured materials in the lab. In 
addition to a plethora of  natural building blocks, synthetic 
(unnatural) blocks can be designed for specific applications.5,6 
Amino acids and peptides are privileged blocks for self-assembly 
into complex micro/nanostructured objects owing to availability and 
variety of building blocks, amenability to chemical synthesis and 
tuneable structure and function.7 Peptide-based self-assembled 
hydrogels trigged remarkable research interest  in recent years owing 
to biocompatibility and biomimetic properties, with  a plethora of 
technological and biomedical applications.4,7,8,9 Peptide sequences 
(motifs) responsible for peptide/protein self-assembly (aggregation) 
in vivo/vitro can be simplified into self-assembling low molecular 
weight peptides (hydrogelators), amenable to chemical synthesis and 
(bio)chemical elaboration.7,8,9  The peptide sequences RGD and 
IKVAV, displayed by ECM proteins vitronectin and laminin, 
respectively, are important biochemical cues (epitopes).10 
Recognition of the RGD and IKVAV epitopes by cell receptors 
triggers responses such as cell migration and differentiation.11 
Peptide-based hydrogels are made of hydrated networks of self-
assembled fibrils. Peptide constructs containing self-assembly 
modules and biochemical epitopes originate fibrils with the self-
assembly module at the core, decorated with hydrophilic/charged 
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pendant epitopes, available for interaction with biological receptors. 
Minimalist self-assembly peptide motifs can generate nanofibres 
presenting high density display (per mass unit of hydrogelator) of 
pendant epitopes.12,13 A precise hydrophobicity/hydrophilicity 
balance and hydrogen bonding (donor/acceptor) properties seem 
crucial for self-assembly. C-deprotected amino-acids and dipeptides 
N-capped with bulky aromatic moieties e.g. 
fluorenylmethoxycarbonyl (Fmoc), naphthaloyl (Nap), naproxyl 
(Npx), are efficacious  minimalist hydrogelators.4,8,9  Fmoc-capped 
phenylalanine (Fmoc-F) and phenylalanylphenylalanine (Fmoc-FF) 
are well characterized minimalist hydrogelator modules able to 
trigger self-assembly of peptide constructs bearing C-terminal RGD 
epitopes.12,13 Hydrogels with tuneable density display of RGD 
epitopes were obtained by co-assembly of non-gelating Fmoc-RGD 
peptide with hydrogelator Fmoc-FF.13  Simultaneous presentation of 
ECM epitopes RGD and IKVAV on hydrogel nanofibrils was 
demonstrated recently by co-assembly of Fmoc-FFRGD and Fmoc-
FIKVAV hydrogelators. Co-assembled hydrogels showed improved 
biological properties comparing to single-epitope and post-assembly 
mixed hydrogels.12  Potential biological applications of Fmoc-capped 
peptide hydrogelators are compromised by the narrow pH stability 
window of the Fmoc group and toxicity issues related to its 
decomposition by-products and precipitation.14,15  
Peptide-based hydrogelators/hydrogels are particularly sensitive to 
proteolysis by endogenous proteases. Incorporation of non-
proteinogenic amino-acids into peptides can enhance proteolytic 
stability and add conformational restraints to the peptide backbone.16 
Nontoxic, self-assembled hydrogels, resistant to proteolysis and 
responsive to stimuli were built from dehydrodipeptide H-Phe-Phe-
OH (Phe-Phe), containing a dehydrophenylalanine (Phe) 
residue.17  A 3D hydrogel scaffold able to sustain cell penetration 
and growth was prepared by chemical elaboration of the pre-formed 
Phe--Phe hydrogel with a RGD (RGDGG) epitope.18 Bing Xu and 
co-workers demonstrated for the first time that L-Phe-L-Phe and D-
Phe-D-Phe dipeptides N-capped with Non-Steroidal Anti-
Inflammatory Drugs (NSAID), specifically naproxen, (RS)-
flurbiprofen and (R)-flurbiprofen, and (RS)-ibuprofen are effective 
hydrogelators.19 Importantly, the same authors disclosed that 
naproxen N-capped  peptides based on the unnatural dipeptide motif 
D-Phe-D-Phe not only retain the NSAID activity of naproxen but 
display enhanced selectivity for the Cyclooxygenase-2 (COX-2) 
enzyme.20 Recently, Cui and co-workers demonstrated that (S)-
ketoprofen N-capped peptides L-VEVE and D-VEVE display also 
enhanced selectivity for COX-2, despite significant reduction of 
activity comparing to the unconjugated NSAID.21 In previous works 
we demonstrated that dehydrodipeptides N-capped with naproxen 
(Npx) are non-toxic to cells, stable towards proteolysis and produce 
hydrogels displaying rheological properties suitable for biological 
applications.22 The NSAID properties of the naproxen capping 
moiety are likely retained by the hydrogelator molecules.20,21 
Napoxen N-capped dehydrodipeptide-based hydrogels were 
proposed as potential nanocarriers for drug delivery.23  
In this work we explore dehydrodipetide Npx-L-Ala-Z-ΔPhe-OH as 
a minimalist hydrogelator module for synthesizing a gelating 
construct   Npx-L-Ala-Z-Phe-G-R-G-D-G-OH bearing a GRGDG 
adhesion motif. The self-assembly of the peptide construct and the 
drug delivery properties of the hydrogel were studied. The effect of 
the chirality of the hydrogelator block Npx-L-Ala-Z-ΔPhe-OH on the 
self-assembly and drug delivery properties of the peptide construct 
was not addressed in this study.  
   
Results and discussion 
Synthesis 
Peptide construct Npx-L-Ala-Z-Phe-G-R-G-D-G (4), 
consisting of a proteolysis-stable minimalist hydrogelator 
module Npx-L-Ala-Z-Phe-OH (Naproxen-
alanyldehydrophenylalanine) (1) and a pentapeptide (GRGDG) 
RGD epitope was synthesized by combined solution and solid 
phase peptide synthesis. The hydrogelator block was prepared 
by a procedure previously described by us (Scheme 1).19,21 The 
pentapeptide block GRGDG was synthesized by solid phase 
peptide synthesis on chlorotrityl chloride resin by the fluorenyl-
9-methoxycarbonyl (Fmoc) protocol. Pbf (2,2,4,6,7-
pentamethyldihydrobenzofuran-5-sulfonyl) and tert-butyl ester 
groups were deployed  for arginine and aspartic acid side chain 
protection, respectively. Peptides were elongated using Fmoc-
amino acids under diisopropylcarbodiimide (DIC) and 1-
hydroxybenzotriazole (HOBt) coupling conditions. The 
hydrogelator block (1) was coupled to the solid phase anchored 
GRGDG pentapeptide using the DIC/HOBt protocol (Scheme 
1). The hydrogelator-RGD peptide construct was cleaved from 
the resin using 2,2,2-trifluoroethanol in acetic acid and further 
deprotected by treatment with trifluoroacetic acid. The 
hydrogelator-RGD peptide construct Npx-L-Ala-Z-Phe-G-R-
G-D-G (4) was obtained as TFA salt in 45% overall yield. 
The structure of the peptide construct was confirmed by 1D and 
2D 1H and 13C NMR techniques and Mass Spectrometry.  The 
Z-stereochemistry of dehydrophenylalanine residue was 
confirmed by NOE difference experiments. 
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Scheme 1. Synthesis of hydrogelator-RGD peptide construct Npx-L-
Ala-Z-Phe-Gly-Arg-Gly-Asp-Gly-OH (4): a) i) HOBt, DIC, DMF, rt, 
18 h, ii) AcOH/TFE/DCM (1:1:3), rt, 4 h; b) TFA, rt, 5 h. 
Peptide construct Npx-L-Ala-Z-Phe-G-R-G-D-G (4) afforded 
well defined hydrogels in the concentration range 0.32-0.40 
wt% (Figure 1, Figure S1). Gels revealed stable at room 
temperature for extended time periods. It seems plausible to 
ascribe the gelation ability of peptide construct 4 to the 
aggregation propensity of the hydrogelator module (1). 
Interestingly, peptide construct 4 displays a critical gelation 
concentration (cgc) (0.32 wt%, phosphate buffer 0.1 M, pH 6.0) 
significantly lower than hydrogelator block 1 (0.8 wt%, pH 
  
  
5.0).22 The soluble, charged pentapeptide block GRGDG seems 
to contribute to self-assembly, presumably through 
intermolecular salt bridges.  
   
 
 
Figure 1. Hydrogel of peptide construct 4 (0.32 wt%, phosphate buffer 
0.1 M, pH 6.0). 
Fluorescence Spectroscopy Studies 
The intrinsic fluorophore naproxen allows to probe the 
properties of peptide construct (4) both in solution and in gel 
phase.22,23 The fluorescence of peptide construct 4 is dominated 
by naproxen emission (max= 353 nm, exc= 290 nm) (Figure 2). 
The fluorescence emission of peptide 4 shows a weak 
dependence of the solution pH for peptide concentrations well 
below the cgc (2×10-6 M; phosphate buffer 0.1 M) (Figure S2). 
The concentration dependence of the fluorescence emission of 
peptide construct 4 (phosphate buffer, 0.1 M, pH 6) shows a 
decrease in intensity, accompanied by bathochromic shift, of 
the naproxen band (max ~ 350 nm, exc= 290 nm), with 
increasing hydrogelator concentration. A subtle increase in 
emission around 430 nm becomes evident in the normalised 
spectra (inset A, Figure 2) suggesting the formation of 
intermolecular aggregates.22,23 
 
 
 
Figure 2. Concentration dependence of the fluorescence emission of 
peptide construct 4 (phosphate buffer 0.1 M, pH 6, exc= 290 nm). 
Insets:  A: Normalized spectra. B: Concentration dependence of the 
wavelength of maximum emission (max); ratio between the emission 
intensity at 430 nm and at max (I430/Imax). 
 
The concentration dependence of the ratio of emission 
intensities at 430 nm and at max (I430/Imax) together with the 
shift of the wavelength of maximum emission of naproxen, 
point to hydrogel formation (cgc) around 0.3-0.4 wt%, in 
accordance to the value determined experimentally. 
Circular Dichroism  
The circular dichroism (CD) spectrum of the hydrogel of 
peptide construct 4 (0.32 wt%, phosphate buffer 0.1 M, pH 6.0) 
displays a negative band in the far UV region (202 nm) 
characteristic of “random coil” conformation of the peptide 
backbone, i.e. lack of repetitive secondary structure (Figure 
3).24 The strong positive band in the near UV region of the CD 
spectrum (300 nm) is assigned to supramolecular chirality of 
the naphthalene group of naproxen (π-π* transitions).25 The CD 
spectrum of the mechanically broken gel (solution phase) 
(Figure 3) shows a significant reduction in intensity of the 
positive Cotton effect at circa 300 nm accompanied by 
enhancement of the negative band at around 200 nm. This 
suggests that π-π stacking interactions of the naphthalene 
groups of the naproxen moieties play an important role in 
peptide self-assembly.22,23 
 
 
 
Figure 3. CD spectra of peptide construct, 4 (0.32 wt%, phosphate 
buffer, 0.1 M, pH 6.0, 25 ºC) in hydrogel phase and in solution 
(mechanically broken gel). 
  
 TEM Analysis  
The micro/nanostructure of the hydrogel of peptide construct 4 
(phosphate buffer 0.1 M, pH 6.0) was studied by Transmission 
Electron Microscopy (TEM) (Figure 4). TEM images were 
obtained with solutions of peptide construct (0.06 wt%; 
phosphate buffer, 0.1 M, pH 6) well below the cgc (0.32 wt%; 
phosphate buffer, 0.1 M, pH 6.0).  
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Figure 4. TEM image of dried solution of peptide construct 4 (0.060 
wt%; phosphate buffer 0.1 M, pH 6.0) stained with uranyl acetate (scale 
bar 500 nm).  
 
TEM images revealed that peptide construct 4 self-assembles 
into a dense network of long nanofibres displaying an average 
width of 23 nm. The fibres show some degree of flexibility and 
crosslinking.  
 
Rheology 
Viscoelastic properties are essential for biomedical applications 
of hydrogels. ECM surrogates must undergo fast and 
reproducible gelation under mild conditions, be amenable to 
handling at physiological temperature and pH, and display 
mechanical properties that resemble natural tissue (elasticity 
0.1-100 kPa) while sustaining long term cell culture.26 The 
rheological properties of hydrogel of peptide construct 4 and of 
hydrogelator block 1 are summarized in Table 1.  
 
Table 1. Rheological properties of hydrogel of peptide construct (4) 
(0.50 wt%, phosphate buffer 0.1 M, pH 6.0).  
 Dynamic frequency 
sweepc 
Dynamic strain sweepg 
Hydrogel G’ [Pa] G’’ [Pa] G’ [Pa] G’ [Pa] Critical 
strain 
[%] 
4a 1st 
cycled 
581 32 1240 56 3.3 
38f 4f -- -- -- 
2nd 
cyclee 
171 11 192 13 1.0 
247f 18f -- -- -- 
1b  800 117 590 110 0.3 
[a] This work; [b] ref. 22; [c] values at f = 1 Hz, γ = 0.5%, T = 20 ºC, 
[d] after 30 minutes of structural build-up at 20 ºC; [e] after 60 minutes 
of structural build-up at 20 ºC; [f] after shear breaking and 30 minutes 
(1st cycle) or 60 minutes (2nd cycle) of structural build-up; [g] The 
values are taken at f = 1 Hz and T = 20 ºC. 
 
Peptide construct 4 could be dissolved in phosphate buffer upon 
heating, followed by gel formation upon cooling to room 
temperature. The mature hydrogel could be re-dissolved upon 
heating and the heat/cool cycle could be repeated several times. 
The mechanical spectrum (Figure S3C), acquired following gel 
structural build-up for 30 minutes at 20 ºC, revealed very weak 
frequency dependence of the storage modulus (G’). Moreover, 
the storage modulus is over 10 times larger than the loss 
modulus (G’’) (cycle 1, Table 1) indicating a strong physical 
gel in contrast to weak gels.27 The dynamic strain sweep 
spectrum (Figure S3D) reveals that despite a low critical strain 
(3 %) for onset of yielding a large strain (in excess of 100 %) is 
required to fluidize the gel. The mechanically fluidized gel, 
when allowed to rebuild for 30 minutes, still shows (Figure 
S3F) a storage modulus 10 times larger than the loss modulus, 
despite significantly lower values for both  G’ and G’’ (weaker 
gel). Thus, this gel exhibits self-healing.28 A longer time, 60 
minutes at 20 ºC, was required for rebuilding the gel re-heated 
to 65 ºC (cycle 2)  (Figure S4). A weaker gel, characterised by 
significantly lower values for G’ and G’’ and critical strain, was 
obtained in cycle II comparing to cycle I (Table 1, Figure S4C-
D). The mechanically fluidized gel from cycle II, when allowed 
to rebuild for 60 minutes, showed fully recovery of both storage 
and loss moduli (Table 1, Figure S4F). The hydrogel of peptide 
construct 4 shows thermo-reversibility and partial recovery of 
viscoelastic properties, following mechanical fluidization, 
properties that are relevant for biological applications. The 
elasticity of the hydrogel after first breaking up or re-heating 
approaches the lower limit of elasticity of soft biological 
tissues, which might constitute a limitation for specific 
biological applications. 
 
Nanocarrier for Drugs 
We proposed before that the hydrogel of dehydrodipeptide 
Npx-L-Trp-Z-Phe-OH is a potential nanocarrier for drug 
delivery applications.22 In this work we further advance this 
concept using the hydrogel of peptide construct 4 as nanocarrier 
and curcumin as a model drug.    
Curcumin has gained much attention as a potential therapeutic 
agent owing to a plethora of biological activities: anti-
inflammatory, antimicrobial, antioxidant and anticancer and 
high dose tolerance.29 Nonetheless, high plasma concentrations 
of curcumin, required for therapeutic purposes, can be attained 
only through delivery strategies owing to low solubility in 
aqueous media and low bioavailability.30 Curcumin is 
fluorescent in several polar and non-polar media, exhibiting 
intramolecular charge transfer (ICT) in the excited state as well 
as hydrogen bonding in protic solvents.31 
Curcumin was incorporated into the hydrogel (0.4-0.5 wt%, 
phosphate buffer 0.1 M, pH 6), as ethanolic solution (total 
ethanol content bellow 1%), during the gelation phase. Direct 
excitation of curcumin incorporated into the hydrogel results in 
strong emission (max circa 525 nm, exc= 410 nm) indicating 
that curcumin molecules are entrapped/associated with the 
hydrogel fibres, sensing an environment with polarity 
equivalent to acetonitrile (Figure S5 and S6). Spectral overlap 
between hydrogel emission and curcumin absorption allowed to 
study the interaction hydrogel/curcumin by FRET (Förster 
Resonance Energy Transfer).32 Curcumin emission above 480 
nm and reduction of hydrogel emission, upon excitation of the 
  
  
hydrogel aromatic groups (exc= 290 nm), was ascribed to 
FRET (Figure 5). 
 
 
Figure 5. Fluorescence spectra (λexc= 290 nm) of hydrogel of 
dehydrodipeptide 4 (0.4 wt%; phosphate buffer 0.1 M, pH 6.0) with 
curcumin incorporated (3×10-6 M). Inset: Spectral overlap (normalized 
spectra) between hydrogel emission and curcumin absorption in ethanol.  
 
 Fluorescence anisotropy measurements (Table 2) further 
support molecular association between curcumin and the 
hydrogel.33 The FRET efficiency (RET) and the corresponding 
donor-acceptor distances were calculated using equations 3-6 
(see Experimental Section) (Figure 5, Table 2). R0 and rAD   
represent the Förster radius (critical distance) and the donor-
acceptor interaction distances, respectively. The fluorescence 
quantum yield of the hydrogel (energy donor; D = 0.011) was 
determined using the standard method (equation 1, 
Experimental Section).  
Hydrogel concentration has a significant effect on FRET 
efficiency and on the curcumin-hydrogel interaction distances. 
The calculated distances curcumin-hydrogel are of the same 
order of magnitude as those obtained (also by FRET) for non-
covalent binding of curcumin to Human Serum Albumin (HSA) 
(RET = 0.33; R0= 27.44 Å; rAD= 30.95 Å).
34 These results 
strongly suggest a host/guest type molecular interaction 
between the hydrogel fibres (host) and curcumin (guest). 
Lipophilic/amphiphilic hydrogelators are prone to interact with 
cell membranes potentially leading to membrane disruption 
and/or cell lysis. The interaction between the hydrogel and 
model lipidic membranes (Small Unillamellar Vesicles- SUVs 
of egg phosphatidylcholine/cholesterol 7:3) was studied by 
incorporating the FRET donor-acceptor pair curcumin-Nile red 
into SUVs.35,36 The fluorescence quantum yield of curcumin in 
this type of SUVs (in the absence of Nile red) was determined 
as D = 0.069. Pronounced Nile red emission (max = 625 nm) 
was observed in SUVs upon excitation of curcumin (exc= 410 
nm) (Figure 6). Interaction between the SUVs and the hydrogel 
results only in a slight increase of the donor-acceptor distance, 
with a corresponding reduction of FRET efficiency (Figure 6 
and Table 2). Therefore, the SUVs seem to maintain their 
integrity in the presence of the hydrogel. 
 
Figure 6. Fluorescence spectra (exc= 410 nm, negligible direct Nile red 
excitation) of SUVs (egg lecithin/cholesterol 7:3) loaded with curcumin and 
Nile red, before and after interaction with the hydrogel (0.4 wt%; phosphate 
buffer 0.1 M, pH 6.0). 
 
To ascertain the drug delivery potential of the hydrogel we 
studied the interaction between the hydrogel loaded with 
curcumin (1×10-5 M) and SUVs loaded with Nile red (Figure 7). 
The interaction results in hypsochromic shift of the waveength 
of maximum emission of curcumin (max 530→500 nm, exc= 
410 nm) and strong Nile red emission (max= 625 nm).  
Figure 7. Fluorescence spectra (exc= 410 nm) of hydrogel (0.4% 
concentration) loaded with curcumin (1×10-5 M), before and after interaction 
with SUVs containing only Nile red. 
Table 2. FRET efficiencies and donor-acceptor distances for the 
hydrogel-curcumin pair and fluorescence anisotropy values for 
curcumin incorporated into the hydrogel (line 1 and 2) and FRET 
efficiencies and donor-acceptor distances for the curcumin-Nile red pair 
in SUVs (line 3 and 4).  
 RET R0(Å) rAD(Å) anisotropy, 
r 
Hydrogel 0.4 wt% 
loaded with curcumin 
0.31 22.8 26.1 0.276 
Hydrogel 0.5 wt% 0.51 23.0 22.7 0.279 
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 loaded with curcumin 
SUVs loaded with  
curcumin and Nile red 
0.372  
 
36.8 
40.1 -- 
SUVs loaded with 
 curcumin and Nile red 
upon interaction with  
hydrogel 
0.281 43.0 -- 
 
These results strongly suggest transference of curcumin from 
the hydrogel to the lipidic membranes (SUVs) establishing drug 
delivery potential for this gel. Moreover, the RGD epitope 
potentially endows the hydrogel with ability for interacting with 
cell membranes presenting integrin receptors (overexpressed in 
cancer cells).  
 
Docking and MD Simulations  
Molecular recognition of the RGD epitope of hydrogelator 4 by 
cells (over)expressing the v integrin receptor can 
conceptually be used for cell homing to the nanofibres and 
delivery of growth factors or therapeutic agents.37 The 
molecular recognition of peptide construct 4 by the v 
integrin receptor was studied by molecular docking using 
AutoDock 4.2.38 The binding energy and the geometry of 
peptide construct 4 in interaction with the αvβ3 integrin were 
computed (Figure 8 and Table 3). The X-ray structure of the 
cyclic RGD ligand cyclo(RGDf[N-Me]V, bound to the 
extracellular fragment of the αvβ3 integrin was used as reference 
benchmark.39 The experimental geometry could be reproduced 
with a root mean square deviation of 0.23 nm for the heavy 
atoms, validating the docking parameters. 
   
Table 3. Binding energy for the lowest energy conformations 
(arrangement A and B, Figure 8) of peptide construct 4 and for the 
cyclo(RGDf[N-Me]V peptide in interaction with  the αvβ3 integrin.  
Ligand cyclo(RGDf[N-
Me]V) 
Peptide 4 
Pose A Pose B 
Gbind (kcal/mol) -11.75 -12.25 -12.24 
Intermolecular 
Energy (kcal/mol) 
-14.44 -14.93 -14.93 
 
Figure 8. Representation of the interactions between the degenerate lowest 
binding energy conformations of peptide construct 4 (A- arrangement A and 
B- arrangement) and αvβ3 integrin. The protein is represented as cartoon. 
Sticks are used to highlight the protein residues that make contact 
interactions with the ligand. The Mn2+ ions are shown as brown larger 
spheres. 
The lowest binding energy conformations identified for peptide 
construct 4 in interaction with the αvβ3 integrin are degenerate 
(arrangement A and B- Figure 8). Peptide construct 4 is 
positioned between the  and  chains of the integrin exhibiting 
a pose similar to that found for the cyclo(RGDf[N-Me]V) 
ligand in the X-Ray structure of the αvβ3 integrin receptor. The 
arginine residue of the peptide construct interacts through 
hydrogen bonding with the Asp218 residue of the integrin 
receptor. The aspartate residue interacts via a salt bridge with a 
Mn2+ metal ion on the integrin binding site, reproducing the 
interaction seen in the experimental structure.39 An additional 
hydrogen bond, not seen in the experimental structure, is 
established between the aspartate residue of the RGD module 
and the Ser193 residue of the integrin. The deprotonated C-
terminal of peptide 4 interacts with a (different) Mn2+ metal ion 
in the integrin binding site. The hydrogelator module Npx-L-
Ala-Z-Phe of the peptide construct seems not to hinder the 
molecular recognition between RGD epitope and the αvβ3 
integrin receptor. Combining the hydrogelator module with 
other targeting epitopes could be a viable strategy for producing 
hydrogels with tailor-made cell specificity.  
 
In Vitro Studies 
 
For drug delivery purposes the hydrogelator (and hydrogel) must be 
nontoxic and biocompatible.  The toxicity of peptide construct 4 and 
of the hydrogelator block Npx-L-Ala-Z-ΔPhe-OH (1) was evaluated 
with the integrin expressing human skin dermal fibroblasts cell line 
ASF-2 by the MTT assay (Figure 9). 
 
Figure 9. Evaluation of  cell viability of adult human skin fibroblasts 
by the MTT test after 48 hours incubation with peptide construct 4 and 
hydrogelator block 1 (50 μM, 100 μM or 500 M; 10% phosphate 
buffer pH 6.0, 0.1 M in DEMEM cell growth medium). No significant 
differences were observed (P > 0.05). 
 
Hydrogelator block 1 and peptide construct 4 seem not to 
exhibit toxicity in solution in the concentration range 50-500 
μm (Figure 8). It seems that combining the hydrogelator 
module 1 with the RGD targeting module does not elicits 
conjugate toxicity.22,23 The lack of toxicity of the peptide 
construct suggests that the hydrogel might also be 
biocompatible. Further studies are necessary to evaluate the 
biocompatibility of the hydrogel of peptide construct 4. It is 
plausible that the polar charged RGD module is exposed to the 
solvent in the hydrogel fibrils creating a dense multivalent 
display of epitopes available for interaction with integrin 
receptors on cells.12,13 
 
  
  
Proteolytic stability studies 
In previous studies we demonstrated that the naproxen N-capped 
dehydrodipeptide hydrogelators Npx-L-Phe-Z--Phe-OH and Npx-L-
Phe-Z--Abu-OH are resistant to proteolysis by chymotrypsin. 
Peptide Npx-L-Phe-L-Phe-OH readily undergoes proteolysis under 
the same experimental conditions.22 Thus, the proteolytic stability of 
the dehydrodipeptides can be ascribe d to steric, conformational 
and/or electronic effects of the dehydroaminoacid in the scissile 
peptide bond. Peptide 4 was incubated with chymotrypsin and the 
reaction was monitored by HPLC ( = 276 nm; water/acetonitrile, 
1:1 with 0.1% TFA) following the disappearance of the substrate 4 
and the formation of a proteolytic fragment (Figure 10).  
 
Figure 10. Evaluation of the proteolitic stability of peptide 4 in the 
presence of α-chymotrypsin (pH 7.4, 37 ºC) over 48 hours. 
 
Peptide 4  undergoes proteolytic degradation by chymotrypsin with 
50% remaining after 6 hours incubation. The reaction is complete 
after 48 hours. Xu and co-workers reported before that peptides H-L-
Phe-R-G-D-OH and H-L-Phe-L-Phe-R-G-D-OH N-capped with 
nucleobases and C-amidated with glucosamine undergo hydrolysis 
by proteinase K, a protease with broad specificity for aromatic and 
aliphatic amino acids.40 HPLC-MS (ESI, positive ionization) 
monitoring of the reaction revealed that the proteolytic fragment 
displays m/z values 660 and 682, assigned to the sequence Npx-L-
Ala-Z-Phe-G-R-OH ([M+H]+ and [M+Na]+, respectively) (Figure 
S7). Chymotrypsin is specific to peptide bonds were the amino acid 
residue on the carboxyl side (residue P1) carries an aromatic side 
chain (Phe, Trp, Tyr residues).  Thus, it is unlikely that the 
proteolytic fragment observed results from chymotrypsin catalysis.  
The formation of this fragment is plausible through the action of the 
enzyme trypsin- selective towards positively charged amino acid 
residues (Lys, and Arg residues) on position P1. In fact, trypsin and 
chymotrypsin are mutual trace contaminants commonly found in 
enzyme preparations obtained from bovine pancreas. This 
serendipitous result shows that the Phe residue makes the peptide 
hydrogelator block resistant to hydrolysis by chymotrypsin. 
Nonetheless, the dehydroamino acid seems not to prevent hydrolysis 
at positions downstream in the peptide chain.  This result is 
important as a fine balance between proteolytic stability and 
degradability of peptide-based hydrogels is fundamental for 
biological applications.   
 
Conclusions 
In this work we demonstrate that the naproxen N-capped 
dehydrodipeptide Npx-L-Ala-Z-Phe is a stable minimalist 
hydrogelator able to trigger gelation of a RGD construct. 
Peptide construct Npx-L-Ala-Z-Phe-G-R-G-D-G (4) revealed 
nontoxic to cells. Molecular recognition in silico of the RGD 
adhesion motif by the αvβ3 integrin receptor seems not to be 
hindered by the hydrogelator module. The peptide construct 
self-assembles in aqueous buffer into hydrogels made of 
entangled bundles of long fibers. The peptide backbone seems 
to assume a random coil conformation both in solution and gel 
phase.  stacking interactions of the naproxen moieties of the 
hydrogelator module seem to play an important role on peptide 
self-assembly. The hydrogel exhibits viscoelastic properties and 
partial recovery after mechanical fluidization. Curcumin 
incorporated into the hydrogel senses an environment with a 
polarity equivalent to acetonitrile with FRET distances of the 
same order of magnitude as those obtained for non-covalent 
binding of curcumin to HSA/BSA. The hydrogel seems not to 
disrupt SUVs model membranes. Importantly, we were able to 
demonstrate by FRET transfer of curcumin from the hydrogel 
into Nile-Red loaded SUVs. Further studies are necessary to 
evaluate hydrogel biocompatibility and drug delivery to cells. 
In this work peptide construct Npx-L-Ala-Z-Phe-G-R-G-D-G-
OH is used as proof of concept that combining minimalist 
naproxen N-capped dehydrodipeptide hydrogelators with 
peptide bioepitopes is an efficient approach to produce 
functional hydrogels. The rheological and drug delivery 
properties of the hydrogels can plausibly be fine-tuned by the 
structure of the hydrogelator block.  
 
 
Experimental 
Melting points (ºC) were determined in a Gallenkamp apparatus 
and are uncorrected. 1H and 13C NMR spectra were recorded on 
a Bruker Avance III at 400 and 100.6 MHz, respectively, or in a 
Varian Unity Plus 300 at 300 and 75.4 MHz, respectively. 1H–
1H spin–spin decoupling and DEPT θ 45º were used. HMQC 
and HMBC were used to attribute some signals. Chemical shifts 
(δ) are given in parts per million (ppm) and coupling constants 
(J) in Hertz (Hz). High resolution mass spectrometry (HRMS) 
data were recorded by the mass spectrometry service of the 
University of Vigo, Spain. Elemental analysis was performed 
on a LECO CHNS 932 elemental analyzer. Column 
chromatography was performed on Macherey–Nagel silica gel 
230–400 mesh. Petroleum ether refers to the boiling range 40–
60 °C. Solid Phase Peptide Synthesis (SPPS) was carried out 
using 2-chlorotrytil chloride resin (100-200 mesh) 1% DVB, 
with a loading capacity of 1.4 mmol g-1. All solutions were 
made up with ultra filtered (18 MΩ) water from a Barnstead 
Nanopure system. Phosphate buffers were prepared from 
NaH2PO4 and Na2HPO4 with a final concentration of 0.1 m. 
Phosphate-buffered saline (PBS) was prepared from 2.7 mm 
KCl, 137 mm NaCl, 10 mm Na2HPO4.2H2O and 1.8 mm 
KH2PO4 with pH 7.39.  
 
Synthesis 
Dehydrodipeptide Npx-L-Ala-Z-ΔPhe-OH (1) was synthesized 
following the methodology previously described by us.22  
Synthesis of Npx-L-Ala-Z-ΔPhe-Gly-L-Arg(Pbf)-Gly-L-Asp(OtBu)-
Gly-OH (3): Fmoc-Gly-OH (1.20 equiv (resin), 0.50 g, 1.68 mmol) 
was dissolved in dry DCM (10 mL). DIPEA (4.00 equiv (Fmoc-Gly-
OH), 1.16 mL, 6.72 mmol) and the resin (1.00 g) were added. The 
mixture was left stirring at room temperature for 6 hours. The resin 
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was filtered and washed successively with a mixture of 
DCM/MeOH/DIPEA (17:2:1, 3×10 mL), DCM (3×10 mL), DMF 
(3×10 mL) and DCM (3×10 mL). The resin was left drying under 
reduced pressure overnight. Resin loading (0.89 mmol g-1) was 
calculated by measuring by the absorbance of the dibenzofulvene-
piperidine adduct at 290 nm. After washing the resin with DMF 
(2×10 mL), a solution of 20% piperidine in DMF (10 mL) was 
added. The mixture was left stirring at rt for 2 hours. The resin was 
filtered and washed successively with DMF (2×10 mL), 2-propanol 
(2×10 mL), DMF (2×10 mL) and 2-propanol (2×10 mL). The TNBS 
test was used to verify the cleavage of the Fmoc group. Fmoc-L-
Asp(OtBu)-OH (3.00 equiv) 1-hydroxybenzotriazole (HOBt) (3.00 
equiv) and N,N'-diisopropylcarbodiimide (DIC) (3.00 equiv) were 
dissolved in DMF (10 mL). The solution was added to the resin and 
the mixture was left stirring at room temperature overnight. The 
resin was filtered and washed successively with DMF (3×10 mL) 
and DCM (3×10 mL). The coupling was verified by the TNBS test. 
The cleavage of the Fmoc group and coupling of the amino acids 
were repeated for Fmoc-Gly-OH (3.00 equiv), Fmoc-L-Arg(Pbf)-OH 
(3.00 equiv), Fmoc-Gly-OH (3.00 equiv) and peptide 1 (2.00 equiv). 
A mixture of AcOH/TFE/DCM (1:1:3, 20 mL) was added to the 
resin and it was left stirring at room temperature for 4 hours. The 
solution was filtered and the solvent removed under reduced 
pressure. Precipitation with diethyl ether afforded compound 3 (0.55 
g, 51%) as a pale pink solid; 1H NMR (400 MHz, DMSO-d6, δ): 1.29 
(d, J = 6.8 Hz, 3H, CH3 Ala), 1.34 (s, 9H, 3×CH3), 1.34-1.42 (m, 2H, 
γCH2 Arg), 1.38 (s, 6H, 2×CH3), 1.41 (d, J = 7.2 Hz, 3H, CH3 Npx), 
1.42-1.56 (m, 1H, βCH Arg), 1.61-1.70 (m, 1H, βCH Arg), 1.98 (s, 
3H, CH3 Pbf), 2.40-2.47 (m, 1H, βCH Asp), 2.41 (s, 3H, CH3 Pbf), 
2.47 (s, 3H, CH3 Pbf), 2.65 (dd, J = 5.4 and 15.8 Hz, 1H, βCH Asp), 
2.93 (s, 2H, CH2 Pbf), 2.98-3.01 (m, 2H, δCH2 Arg), 3.64-3.77 (m, 
6H, 3×CH2 Gly), 3.78-3.86 (m, 1H, CH Npx), 3.84 (s, 3H, OCH3), 
4.24-4.30 (m, 1H, αCH Arg), 4.37-4.41 (m, 1H, αCH Ala), 4.61-4.67 
(m, 1H, αCH Asp), 6.59 (vbs, 2H, 2×NH Arg), 7.03 (brs, 1H, εNH 
Arg), 7.08-7.11 (m, 1H, Ar H Npx), 7.10 (s, 1H, βCH), 7.21-7.27 
(m, 4H, Ar H Npx, 3×Ar H ΔPhe), 7.43 (dd, J = 1.6 and 8.8 Hz, 1H, 
Ar H Npx), 7.49-7.51 (m, 2H, Ar H ΔPhe), 7.68-7.74 (m, 3H, Ar H 
Npx), 7.87 (d, J = 7.6 Hz, 1H, αNH Arg), 8.00-8.02 (m, 1H, NH 
RGDG), 8.14-8.20 (m, 3H, NH Asp, NH GRGD, NH RGD), 8.36 (d, 
J = 6.0 Hz, 1H, NH Ala), 9.72 (s, 1H, NH ΔPhe); 13C NMR (100.6 
MHz, DMSO-d6, δ): 12.26 (CH3 Pbf), 17.04 (CH3 Ala), 17.59 (CH3 
Pbf), 18.94 (CH3 Npx, CH3 Pbf), 25.26 (γCH2 Arg), 27.63 (3×CH3), 
28.29 (2×CH3), 29.19 (βCH2 Arg), 37.53 (βCH2 Asp), 41.18 (CH2 
Gly), 41.98 (CH2 Gly), 42.45 (CH2 Pbf), 42.72 (CH2 Gly), 43.74 
(δCH2 Arg), 44.41 (CH Npx), 48.87 (αCH Ala), 49.25 (αCH Asp), 
52.24 (αCH Arg), 55.11 (OCH3 Npx), 80.16 (C(CH3)3), 86.27 (2-C 
Pbf), 105.65 (CH Npx), 116.25 (C Pbf), 118.44 (CH Npx), 124.31 
(C Pbf), 125.42 (CH Npx), 126.49 (CH Npx), 126.60 (CH Npx), 
128.32 (C Npx), 128.36 (αC), 128.41 (2×CH ΔPhe), 128.66 (CH 
ΔPhe), 128.77 (βCH ΔPhe), 129.06 (CH Npx), 129.54 (2×CH 
ΔPhe), 131.42 (C Pbf), 133.08 (C Npx), 133.72 (Ci ΔPhe), 134.20 (C 
Pbf), 137.09 (C-2 Npx), 137.25 (C Pbf), 156.16 (C=N Arg), 156.93 
(C-6 Npx), 157.42 (C Pbf), 164.93 (C=O ΔPhe), 168.60 (C=O 
RGD), 168.80 (C=O GRGD), 169.24 (C=O Asp), 170.39 (C=O 
Asp), 171.06 (C=O RGDG), 171.72 (C=O Arg), 172.51 (C=O Ala), 
173.98 (C=O Npx); HRMS (ESI) m/z: [M+H]+ calcd for 
C59H77N10O15S
+ 1197.52851; found, 1197.52727. 
Synthesis of Npx-L-Ala-Z-ΔPhe-Gly-L-Arg-Gly-L-Asp-Gly-OH,TFA 
(4): TFA (6 mL mmol-1) was added to Npx-L-Ala-Z-ΔPhe-Gly-L-
Arg(Pbf)-Gly-L-Asp(OtBu)-Gly-OH (2) (0.54 g, 0.45 mmol) and the 
mixture was left stirring at room temperature for 5 hours. The 
solvent was removed under reduced pressure. Diethyl ether was 
added and the solvent removed again under reduced pressure. 
Precipitation with diethyl ether afforded compound 4 (0.40 g, 89%) 
as a beije solid; 1H NMR (400 MHz, DMSO-d6, δ): 1.30 (d, J = 6.8 
Hz, 3H, CH3 Ala), 1.42 (d, J = 6.8 Hz, 3H, CH3 Npx), 1.49-1.55 (m, 
3H, CH Arg), 1.68-1.77 (m, 1H, CH Arg), 2.48-2.49 (m, 1H, βCH 
Asp), 2.65-2.70 (m, 1H, βCH Asp), 3.06-3.08 (m, 2H, δCH2 Arg), 
3.69-3.76 (m, 6H, 3×CH2 Gly), 3.82-3.85 (m, 1H, CH Npx), 3.84 (s, 
3H, OCH3), 3.97 (brs, 3H, NH3
+), 4.29-4.32 (m, 1H, αCH Arg), 
4.37-4.40 (m, 1H, αCH Ala), 4.59-4.64 (m, 1H, αCH Asp), 6.83 (brs, 
1H, NH), 7.09-7.12 (m, 1H, Ar H Npx), 7.11 (s, 1H, βCH), 7.22-
7.27 (m, 4H, Ar H Npx, 3×Ar H ΔPhe), 7.42-7.45 (m, 2H, Ar H 
Npx, εNH Arg), 7.49-7.51 (m, 2H, 2×Ar H ΔPhe), 7.68-7.72 (m, 3H, 
3×Ar H Npx), 7.90 (d, J = 8.0 Hz, 1H, αNH Arg), 8.12 (t, J = 5.8 
Hz, 1H, NH RGDG), 8.16-8.22 (m, 3H, NH Asp, NH GRGD, NH 
GRGD), 8.38 (d, J = 6.4 Hz, 1H, NH Ala), 9.71 (s, 1H, NH ΔPhe); 
13C NMR (100.6 MHz, DMSO-d6, δ): 17.03 (CH3 Ala), 18.95 (CH3 
Npx), 24.87 (CH2 Arg), 29.06 (CH2 Arg), 36.33 (βCH2 Asp), 40.40 
(δCH2 Arg), 40.81 (CH2 Gly), 41.82 (CH2 Gly), 42.73 (CH2 Gly), 
44.41 (CH Npx), 48.92 (αCH Ala), 49.30 (αCH Asp), 52.07 (αCH 
Arg), 55.13 (OCH3 Npx), 105.66 (CH Npx), 118.47 (CH Npx), 
125.44 (CH Npx), 126.49 (CH Npx), 126.63 (CH Npx), 127.38 (αC), 
128.33 (C Npx), 128.45 (2×CH ΔPhe), 128.74 and 128.84 (CH ΔPhe 
and βCH ΔPhe), 129.08 (CH Npx), 129.55 (2×CH ΔPhe), 133.09 (C 
Npx), 133.68 (Ci ΔPhe), 137.09 (C-2 Npx), 156.61 (C=N Arg), 
156.95 (C-6 Npx), 164.95 (C=O ΔPhe), 168.62 (C=O RGD), 168.83 
(C=O GRGD), 170.93 (C=O Asp and C=O RGDG), 171.59 and 
171.61 (C=O Arg and C=O Asp), 172.58 (C=O Ala), 174.08 (C=O 
Npx); HRMS (ESI) m/z: [M]+ calcd for C42H53N10O12
+ 889.38389; 
found, 889.38563. 
Self-assembly in buffer: Briefly, compounds were weighted into 
a sample vial, buffer was added and the mixture was heated to 
80 ºC and left to cool at room temperature or at 37 ºC. 
 
Vesicles preparation: Small unilamellar vesicles (SUVs) of 
egg-PC/cholesterol 7:3 were used as model membranes. 1,2-
diacyl-sn-glycero-3-phosphocholine from egg yolk (Egg-PC), 
and cholesterol (Ch) were obtained from Sigma-Aldrich. For 
SUVs preparation, defined volumes of stock solutions of lipids 
and dyes (curcumin and Nile red) in ethanol were injected 
together, under vigorous stirring, into aqueous buffer solution 
(10 mM Tris-HCl buffer, pH=7.4), at room temperature 
(ethanolic injection method).35 The final total lipid 
concentration was 1 mM, with a dye/lipid molar ratio of 1:500. 
 
Spectroscopic measurements: All solutions were prepared using 
spectroscopic grade solvents and Milli-Q grade water. For 
incorporating curcumin into hydrogels, a stock solution of curcumin 
in ethanol was added to the solution of hydrogelator during the 
gelation process. The ethanol content was kept below 1%.  
Absorption spectra were recorded in a Shimadzu UV-3101 PC 
UV-Vis-NIR spectrophotometer. Fluorescence measurements 
were performed using a Fluorolog 3 spectrofluorimeter, 
equipped with double monochromators in both excitation and 
emission, Glan-Thompson polarizers and a temperature 
controlled cuvette holder. Fluorescence spectra were corrected 
for the instrumental response of the system.  
The fluorescence quantum yields, s, were determined by the 
standard method (equation 1),41  
                                                  
              (1) 
  
  
 
where A is the absorbance at the excitation wavelength, F the 
integrated emission area and n is the refraction index of the 
solvents. Subscripts refer to the reference (r) or sample (s) 
compound. The absorbance value at excitation wavelength was 
always less than 0.1, in order to avoid inner filter effects.  
L-Tryptophan in aqueous phosphate buffer solution (pH=7.2) 
(R = 0.14 at 25 °C)
42 and fluorescein in 0.1 M NaOH solution 
(R = 0.93 at 25 °C)
43 were used as references for 
determination of the fluorescence quantum yield of the 
hydrogel and the dye curcumin incorporated into lipid vesicles, 
respectively.  
The steady-state fluorescence anisotropy, r, is calculated by 
equation 2, 
   (2) 
where IVV and IVH are the intensities of the emission spectra 
obtained with vertical and horizontal polarization, respectively 
(for vertically polarized excitation light), and G is the 
instrument correction factor, 
 
 
 
 
where IHV and IHH are the emission intensities obtained with 
vertical and horizontal polarization (for horizontally polarized 
excitation light). 
Förster Resonance Energy Transfer (FRET) measurements: 
The interaction of hydrogels with model membranes was 
investigated by FRET. FRET efficiency, RET, defined as the 
proportion of donor molecules that have transferred their excess 
energy to acceptor molecules, can be obtained by taking the 
ratio of the donor integrated fluorescence intensities in the 
presence of acceptor (FDA) and in the absence of acceptor (FD) 
(equation 3), 
 
 
                                                                           (3) 
                                      
 
The distance between donor and acceptor molecules can be 
determined through the FRET efficiency (equation 4),  
 
 
 
    (4) 
 
where R0, Förster radius (critical distance), can be obtained 
from the spectral overlap, J(λ), between the donor emission and 
the acceptor absorption, according to equations 5 and 6 (with R0 
in Å,  in nm, A() in m
-1 cm-1) 
 
 
                       (5) 
 
 
                      (6) 
Where     
is the orientational factor assuming random orientation of the 
dyes,  is the fluorescence quantum yield of the donor in the 
absence of energy transfer, n is the refraction index of the 
medium, ID(λ) is the fluorescence spectrum of the donor 
normalized so that 
 
 
, 
and A(λ) is the molar absorption coefficient of the acceptor.
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Circular dichroism: The CD spectra were recorded at 20 ºC on 
a Chirascan spectropolarimeter (Applied Photophysics, UK). 
Peptide hydrogels were loaded into 0.1 mm quartz cells. 
Spectra displaying absorbance <2 at any measured point, were 
acquired with 0.5 nm step, 1 nm bandwidth and 1 second 
collection time per step, taking three averages. The post-
acquisition smoothing tool from Chirascan software was used 
to remove random noise elements from the averaged spectra. A 
residual plot was generated for each curve to exclude distortion 
effects during the smoothing process. Following background 
correction, the CD data were normalized to molarmean residue 
ellipticity. 
 
Transmission electron microscopy: TEM experiments were 
performed using a Philips CM20 transmission electron 
microscope operated at 200 kV. The shiny side of 300 mesh Cu 
grids coated with a carbon film (Agar Scientific, UK) was 
placed over one drop of the peptide solution (0.060 wt% in 
phosphate buffer pH 6, 0.1 m) for 1 minute. The excess solution 
was removed and the shiny side of the grid was placed over a 
drop of aqueous uranyl acetate (1 wt%) (Agar Scientific, UK) 
for 1 minute. The excess solution was removed and the grid 
was allowed to dry at room temperture.  
 
Rheology: Rheological experiments were performed on a 
PaarPhysica MCR300 stress-controlled rheometer, equipped 
with a temperature controlled Couette geometry (diameter 10 
mm). The hydrogel of peptide construct (0.5 wt%, phosphate 
buffer pH 6, 0.1 m) was heated to 65 ºC and transferred to the 
rheometer, pre-programmed to 65 ºC. During the temperature 
cooling ramp (5 ºC min-1), the solution/gel was tested at 1 Hz 
and 0.5% strain. In the kinetic studies, the gel was sheared at 1 
Hz, 0.5% strain and 20 ºC. Dynamic frequency sweeps were 
performed at 0.5 % strain and 20 ºC. During the strain sweep 
experiments the gel was submitted to different strains (0.1 to 
500%), at constant frequency (1 Hz) and temperature (20 ºC). 
For the second cycle, the rheometer was heated to 65 ºC and the 
cycle repeated.  
MTT assay: Adult human skin fibroblasts (ASF-2 cells) were 
maintained at 37 ºC in a humidified 5% CO2 atmosphere grown 
in Dulbecco´s Modified Eagle’s Medium (DMEM, Sigma-
Aldrich, St. Louis, MO, USA) supplemented with 10% fetal 
bovine serum (FBS, Lonza, Verviers, Belgium), 10 mm HEPES 
and 1% antibiotic/antimycotic solution (Sigma-Aldrich, St. 
Louis, MO, USA). Prior to culture, cells within a sub-confluent 
monolayer were trypsinized using trypsin (0.05%)-EDTA.4Na 
(0.53 mm) solution and resuspended in DMEM to obtain a cell 
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concentration of around 50 000 cells per mL. The cells were 
plated in 96-multiwell culture plates (100 μL per well) 24 hours 
before incubation. 5.0 mm peptide solutions in phosphate buffer 
(0.1 m, pH 8)  were used to prepare solutions of 50 μm, 100 μm 
and 500 μm in DMEM. Solutions of phosphate buffer (0.1 m, 
pH 8) at 1%, 2% and 10% in DMEM were used as controls. 
100 μL aliquots of buffer controls and peptide solutions were 
placed into the wells of the plate with the cell culture, with 
three replicas of each. The plate was incubated at 37 ºC for 48 
hours. Cells were then incubated for 60 minutes with MTT [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 
Sigma-Aldrich, St. Louis, MO, USA] to a final concentration of 
0.5 mg mL-1. Then, the medium was removed, and the 
formazan crystals formed by the cell’s capacity to reduce MTT 
were dissolved with a 50:50 (v/v) DMSO:ethanol solution, and 
absorbance measured at 570 nm (with background subtraction 
at 690 nm), in a SpectroMax Plus384 absorbance microplate 
reader. The results were expressed as percentage relative to the 
control (cells with buffer solution). 
Molecular dynamics simulations: The molecular structure of the 
RGD dehydropeptides were designed with the program PyMOL.44 
The α,β-dehydroamino acid, ΔPhe, was parameterized and validated 
in previous work by the authors,22,23 and the topology (bonded and 
non bonded parameters) was based on the equivalent encoded amino 
acid present in the GROMOS 54a7 force field.45 The peptides were 
designed in extended conformation and placed in dodecahedral 
boxes of water considering a hydration layer of at least 1.5 nm 
between the peptide and the walls in all directions; systems contain 
circa 3250-3300 water molecules. The Simple Point Charge (SPC) 
water model was used.46 Boxes were made neutral with the addition 
of one Na+ ion. Each peptide was energy minimized with a steepest 
descent algorithm, and submitted to an equilibration step of 1 ns. 
After that, a production run of 10 ns of NPT MD was perfomed at 
310K and 1 atm with a Berendsen bath with τ = 0.10 ps. The 
SETTLE algorithm47 was used to constrain bond lengths and angles 
of water molecules, while the bond lengths and angles of peptides 
were constrained with the LINCS algorithm48 which allowed the use 
of a 2 fs timestep. For the treatment of long-range interactions, we 
used the reaction field method, with a cut-off of 1.4 nm and a 
dielectric constant of ε = 54 (corresponding to SPC water). The van 
der Waals interactions were truncated with a twin-range cut-off of 
0.8 and 1.4 nm. All simulations were run with the GROMACS 4.5.4 
software package.49 AutoDock 4.238 was used to study the molecular 
recognition of peptide construct 4 by the αvβ3 integrin receptor. A 
detailed description of the experimental protocols used for the 
docking experiments can be found in the Supporting Information.  
 
 
Proteolytic stability: Diluted solutions of peptide 4 (300 l; 0.5 mg 
mL-1; phosphate buffer 0.1 M, pH 7.5) were incubated in triplicate 
with α-chymotrypsin (from bovine pancreas, type I-S, Sigma-
Aldrich) (300 l; 0.5 mg mL-1; 51.3 U mL-1). Samples were taken at 
0 hrs, 2 hrs, 4 hrs, 8 hrs, 12 hrs, 24 hrs, 49 hrs and 78 hrs and 
analysed by HPLC ( = 276 nm; water/acetonitrile, 1:1 with 0.1% 
TFA, flow rate 1.2 ml.min-1). The percentage of substrate (peptide 4) 
remaining was calculated by comparing the chromatographic area of 
the peak of peptide 4 (retention time 2.35 min) at each time point 
with the area in solutions without chymotrypsin. The percentage of 
the proteolytic fragment was calculated by comparing the 
chromatographic area of the peak (retention time 3.30 min) of the 
proteplytic fragment at each time point with the area of the 
proteolitic fragment after 49 hrs (reaction complete). The 
hydrogelator block Npx-L-Ala-Phe-OH (retention time 4.50 min) 
was used as control. Non-enzymatic hydrolysis was excluded by 
analysing peptide solutions without chymotrypsin at each time point.  
To get insight into the structure of the proteolytic fragment reaction 
mixtures were analysed in triplicate at each time point by HPLC-MS 
(ESI, positive ionization) (water/acetonitrile, 1:1 with 0.1% formic 
acid; flow rate 0.4 mL min-1). 
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